Response to interferon alfa-2b in a patient with systemic mastocytosis - PubMed (original) (raw)
Clinical Trial
. 1992 Feb 27;326(9):619-23.
doi: 10.1056/NEJM199202273260907.
Affiliations
- PMID: 1370856
- DOI: 10.1056/NEJM199202273260907
Free article
Clinical Trial
Response to interferon alfa-2b in a patient with systemic mastocytosis
H C Kluin-Nelemans et al. N Engl J Med. 1992.
Free article
No abstract available
Comment in
- Systemic mastocytosis.
Austen KF. Austen KF. N Engl J Med. 1992 Feb 27;326(9):639-40. doi: 10.1056/NEJM199202273260912. N Engl J Med. 1992. PMID: 1734257 Clinical Trial. No abstract available.
Similar articles
- Treatment of three patients with systemic mastocytosis with interferon alpha-2b.
Worobec AS, Kirshenbaum AS, Schwartz LB, Metcalfe DD. Worobec AS, et al. Leuk Lymphoma. 1996 Aug;22(5-6):501-8. doi: 10.3109/10428199609054789. Leuk Lymphoma. 1996. PMID: 8882964 - [System mastocytosis: presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b].
de las Nieves M, Poveda F, Queipo de Llano MP, González-Hermoso C. de las Nieves M, et al. Sangre (Barc). 1997 Oct;42(5):430-1. Sangre (Barc). 1997. PMID: 9424749 Spanish. No abstract available. - Histamine metabolism in mastocytosis patients treated with interferon alpha-2b.
Granerus G, Lönnqvist B, Roupe G. Granerus G, et al. Inflamm Res. 1996 Mar;45 Suppl 1:S41-3. doi: 10.1007/BF03354080. Inflamm Res. 1996. PMID: 8696923 No abstract available. - [Lymphocytic ascites revealing systemic mastocytosis].
Essner C, Thiefin G, Diebold MD, Pignon B, Caulet T, Zeitoun P. Essner C, et al. Gastroenterol Clin Biol. 1995 Nov;19(11):948-51. Gastroenterol Clin Biol. 1995. PMID: 8746056 Review. French. - Interferon-α treatment in systemic mastocytosis.
Bjerrum OW. Bjerrum OW. Curr Drug Targets. 2011 Mar 1;12(3):433-6. doi: 10.2174/138945011794815293. Curr Drug Targets. 2011. PMID: 21143153 Review.
Cited by
- Management of Advanced Systemic Mastocytosis: Clinical Challenges.
Tremblay D, Wagner NE, Mascarenhas J. Tremblay D, et al. J Blood Med. 2024 Sep 11;15:421-433. doi: 10.2147/JBM.S366367. eCollection 2024. J Blood Med. 2024. PMID: 39279879 Free PMC article. Review. - Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis.
Alyamany R, Albachir CA, Alsaleh S, Hamad A, Abdulwali SK, Alotaibi AS, Ahmed SO, Alfayez M. Alyamany R, et al. J Hematol. 2024 Jun;13(3):128-136. doi: 10.14740/jh1279. Epub 2024 Jun 28. J Hematol. 2024. PMID: 38993735 Free PMC article. - Autoantibodies to type I interferons in patients with systemic mastocytosis.
Cao V, Lee SJ, Bai Y, Holland SM, Rosen LB, Metcalfe DD, Komarow HD. Cao V, et al. J Allergy Clin Immunol Glob. 2024 May 3;3(3):100273. doi: 10.1016/j.jacig.2024.100273. eCollection 2024 Aug. J Allergy Clin Immunol Glob. 2024. PMID: 38817344 Free PMC article. - A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis.
Gülen T. Gülen T. Diagnostics (Basel). 2023 Oct 25;13(21):3307. doi: 10.3390/diagnostics13213307. Diagnostics (Basel). 2023. PMID: 37958203 Free PMC article. Review. - Treatment of Indolent and Advanced Systemic Mastocytosis.
Buonomo A, Nucera E, Criscuolo M. Buonomo A, et al. Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022040. doi: 10.4084/MJHID.2022.040. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35615325 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources